Literature DB >> 23442945

Detection and quantification of myocardial perfusion defects by resting single-phase 64-slice cardiac computed tomography angiography compared with SPECT myocardial perfusion imaging.

Mohit Gupta1, Jigar Kadakia, Borut Jug, Song Shou Mao, Matthew J Budoff.   

Abstract

OBJECTIVE: Hypoenhanced regions on cardiac computed tomography angiography (CCTA) correlate with myocardial hypoperfusion. We evaluated the ability of resting single-phase 64-slice CCTA to detect the presence of myocardial infarction (MI) compared with nuclear myocardial perfusion imaging (MPI).
METHODS: One hundred and forty symptomatic patients (age 66±12 years, 64% men) with an irreversible perfusion defect (n=69) or a normal/reversible perfusion defect (n=71) on MPI were subjected to CCTA for further evaluation. MI on CCTA was detected visually on the basis of areas of hypoattenuation (dark) in the myocardium and the corresponding Hounsfield Units (HU) were measured.
RESULTS: CCTA accurately detected MI in 62 patients with an irreversible perfusion defect on MPI, yielding a sensitivity of 90%, a specificity of 94%, a negative predictive value of 91%, and a positive predictive value of 94%. The mean HU of normal and infarcted left ventricular myocardium was 107±23 and 16±40, respectively (P<0.001). An HU cut-off of 28 detected the presence of myocardial scar with 86% sensitivity and 59% specificity. The infarct volume measured by CCTA correlated well with the summed rest score (r=0.567; P<0.001) and the summed stress score (r=0.489; P<0.001) on MPI. In a substudy of 50 patients, the GE perfusion tool yielded a sensitivity of 92%, a specificity of 73%, an negative predictive value of 91%, and a positive predictive value of 76% in detecting MI.
CONCLUSION: Resting single-phase CCTA is highly accurate in detecting and quantifying MI. This study highlights a novel clinical utility of CCTA in addition to assessment of plaque burden and stenosis with no risk of additional radiation or contrast exposure to the patient.

Entities:  

Mesh:

Year:  2013        PMID: 23442945     DOI: 10.1097/MCA.0b013e32835f2fe5

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Early resting myocardial computed tomography perfusion for the detection of acute coronary syndrome in patients with coronary artery disease.

Authors:  Amit Pursnani; Ashley M Lee; Thomas Mayrhofer; Waleed Ahmed; Shanmugam Uthamalingam; Maros Ferencik; Stefan B Puchner; Fabian Bamberg; Christopher L Schlett; James Udelson; Udo Hoffmann; Brian B Ghoshhajra
Journal:  Circ Cardiovasc Imaging       Date:  2015-03       Impact factor: 7.792

2.  Non-ST elevation myocardial infarction and post-stenting ventricular septal defect in the setting of viral myocarditis.

Authors:  Lilia M Sierra-Galan; Angel L Alberto-Delgado; Ana-Camila Flores-Ventura; Eugenio A Ruesga-Zamora; Raquel Mendoza-Aguilar; Victor A Ferrari
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 3.  Cardiac CT for myocardial ischaemia detection and characterization--comparative analysis.

Authors:  A M Bucher; C N De Cecco; U J Schoepf; R Wang; F G Meinel; S R Binukrishnan; J V Spearman; T J Vogl; B Ruzsics
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

Review 4.  Myocardial perfusion imaging with cardiac computed tomography: state of the art.

Authors:  Amit R Patel; Nicole M Bhave; Victor Mor-Avi
Journal:  J Cardiovasc Transl Res       Date:  2013-08-21       Impact factor: 4.132

5.  Update on Computed Tomography Myocardial Perfusion Imaging.

Authors:  Amita Singh; Victor Mor-Avi; Amit R Patel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2016-05-05

6.  Static CT myocardial perfusion imaging: image quality, artifacts including distribution and diagnostic performance compared to 82Rb PET.

Authors:  João R Inácio; Sriraag Balaji Srinivasan; Terrence D Ruddy; Robert A deKemp; Frank Rybicki; Rob S Beanlands; Benjamin J W Chow; Girish Dwivedi
Journal:  Eur J Hybrid Imaging       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.